Genzyme Corp. (GENZ)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Employees:
500 KENDALL STREET, CAMBRIDGE, MA 02142
6172527500

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 0 Shares Outstanding0 Avg 30-day Volume 7.417 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 0.0 / Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from GENZ instead.

View recent insider trading info

Funds Holding GENZ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GENZ BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

COONEY CHARLES L

  • Director
12,011 2011-12-31 0

SANOFI-AVENTIS

GC MERGER CORP.

  • 10% Owner
253,558,720 2011-04-06 0

MOSCICKI RICHARD A SR VP,CHIEF MEDICAL OFFICER

  • Officer
0 2011-04-04 0

SMITH ALAN E SR VP,CHIEF SCIENTIFIC OFFICER

  • Officer
0 2011-04-04 0

TERMEER HENRI A CHMN, PRESIDENT AND CEO

  • Officer
  • Director
0 2011-04-04 0

WIRTH PETER EXEC VP,LEGAL & CORPORATE DEV.

  • Officer
0 2011-04-04 0

CARPENTER ROBERT J

  • Director
0 2011-04-04 0

WHITWORTH RALPH V

  • Director
2,375 2011-04-04 0

BERTHIAUME DOUGLAS A

  • Director
0 2011-04-04 0

MCGILLICUDY CORNELIUS III

  • Director
0 2011-04-04 0

FENTON DENNIS M

  • Director
0 2011-04-04 0

SYRON RICHARD F/CA

  • Director
0 2011-04-04 0

DZAU VICTOR J

  • Director
0 2011-04-04 0

CSIMMA ZOLTAN A SRVP,CHIEF HUMAN RESOURCES OFF

  • Officer
0 2011-04-04 0

WYZGA MICHAEL S EXECUTIVE VP AND CFO

  • Officer
0 2011-04-04 0

GERAGHTY JAMES A SENIOR VICE PRESIDENT

  • Officer
0 2011-04-04 0

SMITH SANDFORD D EXE VP,PRESIDENT INT'L GROUP

  • Officer
0 2011-04-04 0

BERTOLINI ROBERT J

  • Director
0 2011-04-04 0

BOUDREAUX GAIL

  • Director
0 2011-04-04 0

CANUTE SCOTT A EXECUTIVE VP

  • Officer
0 2011-04-04 0

MEEKER DAVID P EXECVP,CHIEF OPERATING OFFICER

  • Officer
0 2011-04-04 0

DESROSIER THOMAS SR VP, GENERAL COUNSEL

  • Officer
0 2011-04-04 0

AMELLO JASON CORPCONTRLLR,CHIEFACCNTOFFICER

  • Officer
0 2011-04-04 0

BURAKOFF STEVEN

  • Director
0 2011-04-04 0

ENDE ERIC J

  • Director
0 2011-04-04 0

COLLIER EARL M JR EXECUTIVE VICE PRESIDENT

  • Officer
No longer subject to file 2009-12-31 0

BAMFORTH MARK R SR.VP, CORP. OPERATIONS & PHAR

  • Officer
0 2009-05-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments